This site is intended for healthcare professionals

Find disease awareness content and relevant supporting materials

Drug information
06/05/20

Etoposide 20 mg/ml Concentrate for Solution for Infusion

Testicular cancer Etoposide injection is indicated in combination with other approved chemotherapeutic agents for the treatment of first line, recurrent or refractory testicular cancer in adults. Small cell lung cancer Etoposide injection is indicated in combination with other approved chemotherapeutic agents for the treatment of small-cell lung cancer in adults. Hodgkin's lymphoma Etoposide injection is indicated in combination with other approved chemotherapeutic agents for the treatment of Hodgkin's lymphoma in adult and paediatric patients. Non-Hodgkin's lymphoma Etoposide injection is indicated in combination with other approved chemotherapeutic agents for the treatment of non-Hodgkin's lymphoma in adult and paediatric patients. Acute myeloid leukaemia Etoposide injection is indicated in combination with other approved chemotherapeutic agents for the treatment of acute myeloid leukaemia in adult and paediatric patients. Gestational trophoblastic neoplasia Etoposide injection is indicated for first line and second line therapy in combination with other approved chemotherapeutic agents for the treatment of high risk gestational trophoblastic neoplasia in adults. Ovarian cancer Etoposide injection is indicated in combination with other approved chemotherapeutic agents for the treatment of non-epithelial ovarian cancer in adults. Etoposide injection is indicated for the treatment of platinum-resistant/refractory epithelial ovarian cancer in adults.